Tag: Fisher & Paykel Healthcare

AUCKLAND, New Zealand – Fisher & Paykel Healthcare has launched its Evora Full, a compact full-face mask for obstructive sleep apnea, in the United States. The mask has received FDA 510(k) clearance, paying the way for its sale in the U.S. in early May, following launches in Australia, New Zealand, Europe and Canada. “We welcome this clearance from the FDA and look forward to offering this unique full-face mask to our customers and patients,” said Justin Callahan, president-North...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects to make a $700 million investment in land and buildings over the next five years to accommodate future growth, say company officials.  In November, the company was “making good progress” on its third manufacturing facility in Mexico and “earthworks were underway” on its fifth building site in Auckland, said CEO Lewis Gradon.  “Once that fifth building site is complete, our current site here...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects new patient diagnoses for sleep therapy in the second half of its 2022 fiscal year to be at or above the previous year, but there is “uncertainty” with another uptick in the number of COVID-19 cases.  The company reported revenue of $227 million for the first half of the year for its home care products group, which includes products used to treat obstructive sleep apnea, representing only a 0.3% increase.  "Growth...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported total operating revenue of $900 million for the first six months ended Sept. 30, 2021, a 1% decrease compared to the same period the previous financial year.  Net profit after tax was $222 million, a 2% decrease.  “For nearly two years now, our customers have been working selflessly to care for patients during a pandemic,” said Lewis Gradon, managing director and CEO. “Our people and suppliers have...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare has appointed Lisa McIntyre, PhD, as a non-executive director of the company effective Oct. 1, 2021. “Lisa has extensive knowledge in health and technology – with experience in strategy, finance, technology transformation and data analytics,” said Scott St John, chairman of the board. “She has a deep understanding of international markets and a reputation for insight, integrity and transparency.” McIntyre is an...

AUCKLAND, New Zealand – Now that COVID-19 hospitalizations are declining in many parts of the world, dampening the demand for certain respiratory products, the big question during Fisher & Paykel Healthcare’s recent earnings call was, what will the company’s fiscal year 2022 look like?   The company reported operating revenue of $1.97 billion for fiscal year 2021, which ended March 31, 2021, an increase of 56% over the previous year or 61% in constant currency, driven by...

WASHINGTON -- The Senate on Tuesday confirmed Chiquita Brooks-LaSure to head CMS. Brooks-LaSure served in the Obama Administration, where she helped guide the Affordable Care Act through passage and implementation. She also worked as a Democratic staffer for the Ways and Means Committee in the House of Representatives. “AAHomecare congratulates Chiquita Brooks-LaSure on her confirmation as CMS Administrator,” said the association. “Her experience in roles at CMS, HHS and on...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reports operating revenue for the nine months ended Dec. 31, 2020, was up 73% in constant currency compared to the prior comparable period.  In the hospital product group, operating revenue was up 113%, with hardware growing 446% and consumables growing 54%.  “In many parts of the world, we have continued to see an influx of COVID-19 patients requiring hospitalization for respiratory treatment,” said Lewis Gradon,...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare was honored to win a Zenith Award from the American Association for Respiratory Care for the sixth year in a row. The Zenith Awards are considered the “people’s choice” awards of the respiratory care profession, because its recipients are chosen by more than 47,000 respiratory therapists. “We’d like to thank the thousands of respiratory care professionals who are caring for patients during the COVID-19 pandemic...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare was named Company of the Year and its CEO Lewis Gradon was named Chief Executive of the Year in the Deloitte Top 200 Awards sponsored by Deloitte, the New Zealand Herald and New Zealand Media and Entertainment. Judging for the Company of the Year award included the latest financial measures, organizational performance, corporate reputation and approach to environmental management. Judges recognized F&P for its response to the COVID-19 pandemic,...